[Vasoreactivity changes during extracorporeal circulation: effects of halogenated agents].
During cardiopulmonary bypass (CPB), endothelium is exposed to multiple disturbances leading to significant vasomotor tone and vascular systemic resistances (VSR) level modifications. Properties of endothelial function on vascular tone were summarized herein. According bibliographic findings, physiological and clinical impacts of respectively halogenated agents and CPB concerning vasomotor tone were reported. Main effects of halogenated agents administered through oxygenator during CPB were also identified. Usually when administered above one MAC, halogenated agents decreased VSR during hypothermic bypass. Once those mechanisms summarized, increase of halogenated agent's effects on VSR during normothermic CPB was postulated. Assuming that decrease of VSR could be deleterious favoring severe vasoplegia event, clinical experience of administration of isoflurane during CPB among more 4000 patients was retrospectively reported. Incidence of severe vasoplegia was established to 9.5 % in the studied population and this result was similar as others. More over predicting factors of severe vasoplegia were the same as previously reported : severity of preoperative clinical status according Euroscore, hemodynamical instability before induction of anesthesia, surgical procedure complexity and CPB duration. Absence of deleterious effects in SVR decrease when administering isoflurane during normothermic CPB was assumed but prospective comparative studies comparing effects of halogenated agents and other anesthetic agents are needed in order to confirm these findings.
Département d'anesthésie-réanimation, Centre Hospitalier Universitaire de Poitiers, 2 rue de Milèterie, 8602 Poitiers cedex, France. herve.lanquetot@chu- poitiers.fr
H
H
Lanquetot
J-M
JM
Charrière
L
L
Soubiron
S
S
Chauvet
N
N
Mandon
O
O
Vilain
V
V
Carriot
D000368:Aged; D018685:Anesthetics, Inhalation / Q000494:pharmacology*; D005112:Extracorporeal Circulation; D005260:Female; D006219:Halogens; D006801:Humans; D007530:Isoflurane / Q000494:pharmacology*; D008297:Male; D008738:Methyl Ethers / Q000494:pharmacology*; D009129:Muscle Tonus / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D000077149:Sevoflurane; D014655:Vascular Resistance / Q000187:drug effects*; D014666:Vasomotor System / Q000187:drug effects
D018685:Anesthetics, Inhalation; D006219:Halogens; D008738:Methyl Ethers; D000077149:Sevoflurane; D007530:Isoflurane